These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 35872303)

  • 21. Early outcomes of lung transplantation for bronchiolitis obliterans syndrome after allogeneic haematopoietic stem cell transplantation: a single-centre experience.
    Jung HS; Lee JG; Yu WS; Lee CY; Haam SJ; Paik HC
    Interact Cardiovasc Thorac Surg; 2016 Dec; 23(6):914-918. PubMed ID: 27481680
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rapid versus gradual lung function decline in bronchiolitis obliterans syndrome after haematopoietic stem cell transplantation is associated with survival outcome.
    Kwok WC; Liang BM; Lui MMS; Tam TCC; Sim JPY; Tse EWC; Leung AYH; Kwong YL; Lie AKW; Ip MSM; Lam DCL
    Respirology; 2019 May; 24(5):459-466. PubMed ID: 30663178
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of safety and efficacy of allogeneic adipose tissue-derived mesenchymal stem cells in pediatric bronchiolitis obliterans syndrome (BoS) after allogeneic hematopoietic stem cell transplantation (allo-HSCT).
    Mohseni R; Mahdavi Sharif P; Behfar M; Modaresi MR; Shirzadi R; Mardani M; Jafari L; Jafari F; Nikfetrat Z; Hamidieh AA
    Stem Cell Res Ther; 2023 Sep; 14(1):256. PubMed ID: 37726865
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term pulmonary function testing in pediatric bronchiolitis obliterans syndrome after hematopoietic stem cell transplantation.
    Walther S; Rettinger E; Maurer HM; Pommerening H; Jarisch A; Sörensen J; Schubert R; Berres M; Bader P; Zielen S; Jerkic SP
    Pediatr Pulmonol; 2020 Jul; 55(7):1725-1735. PubMed ID: 32369682
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Analysis of pulmonary non-tuberculous mycobacterial infections after lung transplantation.
    Shah SK; McAnally KJ; Seoane L; Lombard GA; LaPlace SG; Lick S; Dhillon GS; Valentine VG
    Transpl Infect Dis; 2016 Aug; 18(4):585-91. PubMed ID: 27368989
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The association of lung function changes with outcomes in children with bronchiolitis obliterans syndrome after hematopoietic stem cell transplantation.
    Jung S; Yoon HM; Yoon J; Park M; Rhee ES; Kim H; Koh KN; Lee JS; Im HJ; Yu J
    Pediatr Pulmonol; 2021 Oct; 56(10):3332-3341. PubMed ID: 34357700
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Outcomes of lung transplantation after allogeneic hematopoietic stem cell transplantation.
    Cheng GS; Edelman JD; Madtes DK; Martin PJ; Flowers ME
    Biol Blood Marrow Transplant; 2014 Aug; 20(8):1169-75. PubMed ID: 24727334
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relevance of Plasma Matrix Metalloproteinase-9 for Bronchiolitis Obliterans Syndrome after Allogeneic Hematopoietic Cell Transplantation.
    Inamoto Y; Martin PJ; Onstad LE; Cheng GS; Williams KM; Pusic I; Ho VT; Arora M; Pidala J; Flowers MED; Gooley TA; Lawler RL; Hansen JA; Lee SJ
    Transplant Cell Ther; 2021 Sep; 27(9):759.e1-759.e8. PubMed ID: 34126278
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Extracorporeal Photopheresis Improves Survival in Hematopoietic Cell Transplant Patients with Bronchiolitis Obliterans Syndrome without Significantly Impacting Measured Pulmonary Functions.
    Hefazi M; Langer KJ; Khera N; Adamski J; Roy V; Winters JL; Gastineau DA; Jacob EK; Kreuter JD; Gandhi MJ; Hogan WJ; Litzow MR; Hashmi SK; Yadav H; Iyer VN; Scott JP; Wylam ME; Cartin-Ceba R; Patnaik MM
    Biol Blood Marrow Transplant; 2018 Sep; 24(9):1906-1913. PubMed ID: 29679771
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biopsy-verified bronchiolitis obliterans and other noninfectious lung pathologies after allogeneic hematopoietic stem cell transplantation.
    Uhlving HH; Andersen CB; Christensen IJ; Gormsen M; Pedersen KD; Buchvald F; Heilmann C; Nielsen KG; Mortensen J; Moser C; Sengeløv H; Müller KG
    Biol Blood Marrow Transplant; 2015 Mar; 21(3):531-8. PubMed ID: 25498923
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk Factor and Clinical Outcome of Bronchiolitis Obliterans Syndrome after Allogeneic Hematopoietic Stem Cell Transplantation.
    Rhee CK; Ha JH; Yoon JH; Cho BS; Min WS; Yoon HK; Lee JW
    Yonsei Med J; 2016 Mar; 57(2):365-72. PubMed ID: 26847288
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CD19(+)CD21(low) B cells and patients at risk for NIH-defined chronic graft-versus-host disease with bronchiolitis obliterans syndrome.
    Kuzmina Z; Krenn K; Petkov V; Körmöczi U; Weigl R; Rottal A; Kalhs P; Mitterbauer M; Ponhold L; Dekan G; Greinix HT; Pickl WF
    Blood; 2013 Mar; 121(10):1886-95. PubMed ID: 23303823
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interstitial lung diseases after hematopoietic stem cell transplantation: New pattern of lung chronic graft-versus-host disease?
    Archer G; Berger I; Bondeelle L; de Margerie-Mellon C; Cassonnet S; de Latour RP; Michonneau D; Chevret S; Bergeron A
    Bone Marrow Transplant; 2023 Jan; 58(1):87-93. PubMed ID: 36309588
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Home Spirometry Telemonitoring for Early Detection of Bronchiolitis Obliterans Syndrome in Patients with Chronic Graft-versus-Host Disease.
    Turner J; He Q; Baker K; Chung L; Lazarevic-Fogelquist A; Bethune D; Hubbard J; Guerriero M; Sheshadri A; Syrjala KL; Martin PJ; Boeckh M; Lee SJ; Gooley T; Flowers ME; Cheng GS
    Transplant Cell Ther; 2021 Jul; 27(7):616.e1-616.e6. PubMed ID: 33781975
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The safety and tolerability of pirfenidone for bronchiolitis obliterans syndrome after hematopoietic cell transplant (STOP-BOS) trial.
    Matthaiou EI; Sharifi H; O'Donnell C; Chiu W; Owyang C; Chatterjee P; Turk I; Johnston L; Brondstetter T; Morris K; Cheng GS; Hsu JL
    Bone Marrow Transplant; 2022 Aug; 57(8):1319-1326. PubMed ID: 35641662
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of Lung Function on Bronchiolitis Obliterans Syndrome and Outcome after Allogeneic Hematopoietic Cell Transplantation with Reduced-Intensity Conditioning.
    Duque-Afonso J; Ihorst G; Waterhouse M; Zeiser R; Wäsch R; Bertz H; Müller-Quernheim J; Finke J; Marks R; Prasse A
    Biol Blood Marrow Transplant; 2018 Nov; 24(11):2277-2284. PubMed ID: 29964193
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A review of the therapeutic potential of the cysteinyl leukotriene antagonist Montelukast in the treatment of bronchiolitis obliterans syndrome following lung and hematopoietic-stem cell transplantation and its possible mechanisms.
    Kordjazy N; Amini S
    Ther Adv Respir Dis; 2024; 18():17534666241232284. PubMed ID: 38504551
    [TBL] [Abstract][Full Text] [Related]  

  • 38. NHANES III equations enhance early detection and mortality prediction of bronchiolitis obliterans syndrome after hematopoietic SCT.
    Williams KM; Hnatiuk O; Mitchell SA; Baird K; Gadalla SM; Steinberg SM; Shelhamer J; Carpenter A; Avila D; Taylor T; Grkovic L; Pulanic D; Comis LE; Blacklock-Schuver B; Gress RE; Pavletic SZ
    Bone Marrow Transplant; 2014 Apr; 49(4):561-6. PubMed ID: 24419526
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Time to explore preventive and novel therapies for bronchiolitis obliterans syndrome after allogeneic hematopoietic stem cell transplantation.
    Sengsayadeth SM; Srivastava S; Jagasia M; Savani BN
    Biol Blood Marrow Transplant; 2012 Oct; 18(10):1479-87. PubMed ID: 22449611
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A prospective molecular surveillance study evaluating the clinical impact of community-acquired respiratory viruses in lung transplant recipients.
    Kumar D; Husain S; Chen MH; Moussa G; Himsworth D; Manuel O; Studer S; Pakstis D; McCurry K; Doucette K; Pilewski J; Janeczko R; Humar A
    Transplantation; 2010 Apr; 89(8):1028-33. PubMed ID: 20075787
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.